title: [Description of type 2 diabetes mellitus in residents of Ile-de-France aged at most 70 years].
abstract: Our study of patients with type 2 diabetes mellitus residing in the Paris area (Ile-de-France) aged 70 years or younger included 1 591 patients examined by national health insurance expert physicians who also filled out a self-administrated questionnaire. Their primary care physicians also answered a questionnaire (79% participation, indicating their personal implication). We found that diabetes was most often discovered during regular check-ups. Single-drug regimens were the most widely used. Sulfamides were prescribed for 77% of the patients. Among the 912 patients who were overweight (BMI > 28 Kg/m2), 34.3% were taking sulfamides alone despite the fact that metformin is recommended as the first intention drug for these patients. Blood pressure control was not satisfactory in 30% of the patients who were treated or not for high blood pressure. This proportion rose to about 50% among treated patients alone. The patients appeared to be knowledgeable about the risk of complications, particularly ocular complications. They were aware of a certain number of messages but the results would suggest difficulty in application.
authors.affiliation: Service Médical de l'Assurance Maladie d'Ile-de-France (SMAMIF), 17/19 avenue de Flandre, 75019 Paris. espps@smamif.org
authors.forename: L
authors.initials: L
authors.lastname: Silvera
authors.forename: D
authors.initials: D
authors.lastname: Simon
authors.forename: B
authors.initials: B
authors.lastname: Trutt
authors.forename: B
authors.initials: B
authors.lastname: Blanchon
authors.forename: M
authors.initials: M
authors.lastname: Parmentier
authors.forename: P
authors.initials: P
authors.lastname: Hecquard
mesh_terms: D000328:Adult; D000368:Aged; D001794:Blood Pressure; D003695:Delivery of Health Care; D003924:Diabetes Mellitus, Type 2 / Q000453:epidemiology* / Q000503:physiopathology / Q000628:therapy; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000145:classification / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D010297:Paris / Q000453:epidemiology
chemical_list: D007004:Hypoglycemic Agents